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Abstract 
Background: Spontaneous abortion is considered as the most complex problem 
during pregnancy. Thrombophilia is resumed as a cause of recurrent pregnancy loss 
(RPL). Glycoprotein IIIa (GPIIIa) gene is involved in thrombosis and abortion. 
Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin II and 
is involved in thrombosis. The most common polymorphism in this gene is the 
insertion/deletion (I/D). 
Objective: In this study, we analyzed the association between ACE I/D and GPIIIa 
c.98C >T polymorphisms in women with unexplained RPL from the north of Iran. 
Materials and Methods: Sample population consisted of 100 women with 
unexplained RPL and 100 controls. The ACE I/D and GPIIIa c.98C>T 
polymorphisms were genotyped by TETRA-ARMS PCR. The association between 
genotypes frequency and RPL were analyzed using χ P2P and exact fisher tests. 
Associated risk with double genotype combinations was also investigated by binary 
logistic regression. 
Results: There was significant association between ACE DD genotype and RPL 
(OR=2.04; 95% CI=0.94-4.44; p=0.036). ACE D Allele was also significantly 
associated with the RPL (OR=1.59; 95% CI=1.05-2.41; p=0.013). No significant 
association was observed between GPIIIa c.98C>T polymorphism and RPL. 
Conclusion: ACE I/D polymorphism may probably be a prognostic factor in female 
family members of women with the history of recurrent abortion. 
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Introduction 
 
ecurrent pregnancy loss (RPL) 
appears a signiﬁcant clinical 
problem affecting approximately 2% 
of women (1). RPL pathophysiology is poorly 
understood. Pregnancy loss may be caused 
by different reasons such as genetic factors, 
immune defect, infection and anatomical 
problem (2). However, even after more 
accurate investigations, as many as 50% of all 
cases remain unexplained (3). Thrombophilia 
has been presumed as a cause of RPL (4, 5). 
Many recent studies have examined the 
mutations incidence and variants in speciﬁc 
thrombophilic genes on women with 
unexplained pregnancy loss (4-10). 
Angiotensin converting enzyme (ACE) is a key 
component in rennin-angiotensin system 
which converts angiotensin I to angiotensin II, 
a potent vasopressor. Many studies have 
been indicated that ACE affects hemostasis 
through different mechanisms, including 
platelet aggregation, blood clotting and 
ﬁbrinolysis (11-14).  
The human ACE gene contains variable 
polymorphic regions that can be used in 
genetic analysis. A well-known polymorphism 
is the insertion/deletion (I/D) of 287 base 
paired (bp) fragment in intron 16 which has 
been extensively investigated (1). 
Furthermore, it has been found that ACE D 
allele leads to increased expression in 
plasminogen activator inhibitor-1 (PAI-1) level, 
which can increase the angiotensin II 
production and enhance the thrombotic events 
risk (15, 16).  
Past studies have been indicated that 
R 
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thrombophilic defects affect pregnancy-
associated thromboembolism such as 
preeclampsia and abortion (11). Few recent 
meta-analysis studies have demonstrated the 
role of ACE I/D polymorphism in increasing 
RPL risk (17, 18). Glycoprotein IIIa (GPIIIa) is 
one of thrombophilic genes involved in 
modulation of vascular thrombosis. The 
GPIIb/GPIIIa is an integrin complex in platelet 
aggregation as a ﬁbrinogen receptor (19). The 
polymorphism c.98C>T in GPIIIa gene causes 
an amino acid substitution (p.L33P), leads to 
the creation of two distinct forms of GPIIb/IIIa 
antigen on platelets (20). This polymorphism 
has been associated with stroke in young 
Caucasian women and risk of premature 
acute coronary syndromes (21). This variation 
also results in spiral artery thrombosis and 
poor placental perfusion, which can explain 
the correlation of this polymorphism with RPL 
(22, 23). 
To date, few studies have established on 
the relationship between thrombophilic genes 
and RPL in Iranian population (24-26). We, 
therefore, determined the association between 
of ACE I/D and GPIIIa c.98C>T 
polymorphisms in women from the northern of 
Iran with unexplained RPL. 
 
Materials and methods 
 
Subjects 
This case-control study was done carried 
out during the 2013-2014 year’s in Sari, Iran. 
A total of 100 women with unexplained RPL 
aged 20-40 yrs and 100 healthy controls aged 
27-44 yrs, with at least two live births and no 
history of abortion, infertility or endometriosis 
were comprised. Prior to enrollment, all 
patients were given an explanation of study 
nature, and written informed consent was 
obtained from all individuals. The study 
protocol was approved by the Clinical 
Research Ethics Committee in Mazandaran 
University of Medical Sciences, Sari, 
Mazandaran. RPL was defined as two or more 
spontaneous consecutive abortions at 5-20 
wks of gestation. Miscarriage history of 
women with unexplained RPL was examined 
and cases with anatomic, chromosomal, 
hormonal, autoimmune or infectious causes 
were excluded from this study. There was no 
pregnancy-related problems such as 
hypertension, diabetes, thyroid abnormalities, 
etc. in none of cases.  
Genotyping 
Genomic DNA was isolated from whole 
blood by a modified Nucleon BACC II method 
from whole blood (Tepnel Life Sciences, 
Manchester, UK). The ACE I/D polymorphism 
was genotyped using two primers and GPIIIa 
c.98C>T polymorphism was genotyped using 
a TETRA-ARMS PCR method (27, 28). The 
GPIIIa c.98C>T polymorphism primers were 
designed by Gene Runner software (version 
3.05) (Table I). The polymerase chain reaction 
(PCR) was performed using standard PCR 
methods with 100-200 ng of DNA template 
and 5 picomol of each primer and PCR 
materials (Cinnagen, Tehran, Iran) in thermal 
cycler (Eppendorf, Hamburg, Germany) as 
reported previously (29).  
PCR conditions for ACE genotyping 
included one step initial denaturation (94PoPC for 
3 min), 35 cycles (94PoPC for 45 sec, 60.5PoPC for 
50 sec, and 72PoPC for 40 sec) and a final 
extension at 72 PoPC for 5 min. PCR conditions 
for GPIIIa genotyping also included one step 
initial denaturation (94PoPC for 3 min), 35 cycles 
(94PoPC for 35 sec, 58PoPC for 40 sec, and 72PoPC 
for 40 sec) and a final extension at 72 PoPC for 5 
min. Then, PCR products were 
electrophoresed in a 1.5% agarose gel 
(Fermentas, Sankt Leon-Rot, Germany).  
 
Statistical analysis 
Association between genotypes frequency 
and RPL were analyzed using χ P2P and Fisher’s 
exact tests. The risk associated with the 
double genotype combinations was also 
investigated by binary logistic regression. 
Data were analyzed by SPSS software 
(version 17.0) and p˂0.05 were considered 
significant56T. 
 
Results 
 
The ACE I/D Alleles were determined 
based on Product size-band; 490 bp for the I 
allele and 190 bp for D allele (Figure 1A). The 
GPIIIa c.98C>T Alleles were also determined 
by bands; 395 bp for the C allele (by primers 
of reverse outer and forward inner), 200 bp for 
T allele (by primers of forward outer and 
reverse inner) and 560 bp as control (by 
primers of outer) (Table I) (Figure 1B). The 
ACE I/D and GPIIIa c.98C>T genotypes in 
women with RPL and control group was in 
accordance with Hardy-Weinberg equilibrium. 
A few samples from each genotype were 
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confirmed by sequencing. The Genotypic and 
allelic frequencies of ACE I/D and GPIIIa 
c.98C>T polymorphisms in women with RPL 
and control group were shown in tables II and 
III. The ACE II genotype was observed in 23% 
of cases, ACE ID genotype in 33% and ACE 
DD genotype in 44%. The GPIIIa c.98C>T 
wild-type genotype (TT) was observed in 84% 
of cases, whereas 16% were heterozygous 
(TC) and no CC genotype was observed. Our 
results showed that, there is a significant 
difference regarding ACEDD genotype 
between cases and control groups (OR=2.04; 
95% CI=0.94-4.44; p=0.036) (Table II).  
Our results also indicated that D Allele is 
statistically associated with RPL (OR=1.59; 
95% CI=1.05-2.41; p=0.013) (Table III). No 
significant difference was observed between 
genotypic and allelic frequencies of GPIIIa 
c.98C>T polymorphism and RPL in case and 
control groups. In combination analysis, there 
was no significant association between 
combination of ACEDD genotype and GPIIIa 
TT genotype with RPL (Table IV). 
 
 
Table I. Primers used for genotyping 
Primer Sequence (5´→3´) Genbank accession No. 
ACE I/D  NG_011648.1  
 Forward CTGGAGACCACTCCCATCCTTTCT  
 Reverse GATGTGGCCATCACATTCGTCAGAT  
GPIIIa c.98C>T    NG_008332.2  
 Forward outer CCTTTCTGTACAACGGTCCT  
 Reverse outer CAGATCTTCTGACTCAAGTCCT  
 Forward inner (C) CTTACAGGCCCTGCGTCC  
 Reverse inner (T) CACAGCGAGGTGAGCACA  
 
 
Table II. Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk of I/I versus (I/D + 
D/D) and (I/I + I/D) versus D/D for RPL was evaluated in dominant and recessive models (n=100) 
 Case  Control  OR (95% CI) p-value 
ACE I/D     
 II 23 31 1.00  
 DI 33 40 1.11 (0.51 - 2.40) 0.455 
 DD 44 29 2.04 (0.94 - 4.44) 0.036$ 
 DI + DD 77 69 1.50 (0.76 - 2.97) 0.104 
 DD 44 29 1.00  
 DI 33 40 0.54 (0.26 - 1.10) 0.097 
 II 23 31 0.48 (0.22 - 1.06) 0.071 
 DI+II 56 71 0.51 (0.28 - 0.93) 0.131 
GPIIIa c.98C>T       
 TT 84 80 1.00  
 TC 16 20 0.76 (0.36 - 1.58) 0.469 
 CC 0 0 - - 
 TC + CC 16 20 0.76 (0.36 - 1.58) 0.469 
OR: odds ratio  CI: confidence interval 
$ significant p-values 
 
 
Table III. Allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL 
 Case  Control  OR (95% CI) p-value 
ACE I/D     
 I 79 (39.5%) 102 (51%) 1.00  
 D 121 (60.5%) 98 (49%) 1.59 (1.05 - 2.41) 0.013$ 
GPIIIa c.98C>T       
 T 184 (92%) 180 (90%) 1.00  
 C 16 (8%) 20 (10%) 0.78 (0.38 - 1.56) 0.491 
Data presented as n (%).    $ Significant p-values 
OR: odds ratio     CI: confidence interval 
 
 
Table IV. Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL 
 Case  Control OR (95% CI) p-value 
ACE/ GPIIIa     
 II/TT 20 26 1.00  
 II/TC 3 5 0.78 (0.10 - 4.59) 0.389 
 DI/TT 28 30 1.21 (0.51 - 2.84) 0.316 
 DI/TC 5 10 0.65 (0.15 - 2.52) 0.255 
 DD/TT 36 24 1.95 (0.83 - 4.57) 0.067 
 DD/TC 8 5 2.08 (0.50 - 9.29) 0.136 
OR: odds ratio     CI: confidence interval 
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Figure 1. Electrophoresis pattern of PCR products for detection of polymorphisms.(A)ACE I/D polymorphism. Band of 490 bp and 
190 bp are as I allele and D allele respectively. (B)GPIIIa c.98C>T polymorphism. Band of 395 bp and 200 bp are as C allele and T 
allele respectively. Band of 560 bp is as control. 
 
Discussion 
 
This study was designed to determine the 
association between certain polymorphisms in 
ACE and GPIIIa genes and RPL in 
Mazandaran province, northern Iran. Changes 
in renin-angiotensin-aldosterone system are 
involved in pathogenesis of pregnancy 
complications such as preeclampsia and fetal 
loss (30, 31). Previous studies elucidated the 
role of ACE I/D polymorphism in susceptibility 
to pregnancy loss (32-36).  
ACE alters hemostasis through some 
mechanisms, including platelet aggregation, 
inﬂuence on ﬁbrinolysis. Some previous 
studies have reported an association between 
the ACE D allele and increased risk of 
thrombosis (15, 37). Data by Fatini et al 
demonstrated that the ACE I/D polymorphism 
may be an important risk factor for RPL (35). 
Buchholz et al also reported that the ACE DD 
genotype leads to increased PAI-1 
concentration and thus correlated with an 
increased risk of RPL in Caucasians (14). 
However, Vettriselvi et al showed no 
signiﬁcant association between the 
frequencies of deletion allele and RPL (1). In 
this study, we found an association between 
ACE I/D polymorphism and RPL in our 
population. This study demonstrated that the 
DD genotype was more prevalent in RPL 
cases (44%) than in controls (29%), and D 
allele by itself might be a risk factor for RPL in 
this population.  
Concerning the GPIIIa c.98C>T 
polymorphism, it seems to increase 
susceptibility to premature acute coronary 
syndrome and risk of stroke in young 
Caucasian women (21). T allele frequency 
was low in all the past studies which is in 
contrast with this study (1%-17%), this may be 
due to small sample size in our study (36, 38, 
39). Yenicesu et al reported that heterozygous 
mutations of GPIIIa c.98C>T (CT) were 
associated with RPL (38). Goodman et al 
showed that GPIIIa L33P can identify women 
at risk for RPL (7). Coulam et al also 
determined the frequency of GPIIIa L33P in 
women with RPL history (40). Our results 
indicated that the GPIIIa c.98 C>T 
polymorphism was not significantly correlated 
with RPL. These results are in agreement with 
the study’s results of, Ozdemir et al, Torabi et 
al, Pihusch et al, Coulam et al, Goodman et al 
and Hohlagschwandtner et al (7, 26, 39-42). 
 
Conclusion 
 
The major finding of this study shows that 
ACE D allele may increase susceptibility to 
RPL. ACE I/D polymorphism could probably 
be investigated as one of the prognostic 
factors in women with RPL history among the 
family members. 
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